Cebix plans $20M raise; J&J shutters research center; coffee compounds may prevent diabetes;

 @FierceBiotech: CRO consolidation to slow in 2012, Icon CEO says. More | Follow @FierceBiotech

 @JohnCFierce: It's good to be the CEO, says BMS chief Lamberto Andreotti at #JPM12. Give him his due, he earned it. Story | Follow@JohnCFierce

 @MaureenFierce: Researchers develop tech to detect inherited MPS disorders. Article | Follow @MaureenFierce

 @RyanMFierce: AstraZeneca taps IMS Health to mine outcomes data, electronic health records and to develop analysis platform. News | Follow @RyanMFierce

 @MarkHFierce: It seems that nanotech delivery advances are getting serious already in 2012. | Follow @MarkHFierce

> San Diego-based Cebix tells VentureWire that it plans to raise $20 million in a new venture round designed to back its work on a new diabetes treatment. Story

> J&J is shutting down a research facility in Montreal that currently employs 126 staffers. Report

> Shire has acquired the U.S. rights to the constipation drug Resolor. Story

Pharma News

 @FiercePharma: That $2B to $3B deal size is Big Pharma's sweet spot: Novartis, Roche and now Sanofi say so. Story | Follow@FiercePharma

> FDA didn't disclose safety panel's ties to Bayer, WSJ says. Article

> Parallel trade puts new crimp on Greek pharma market. News

> Foreign firms reap 60% of China's healthcare stimulus. Story

> $3B or less is Big Pharma's M&A sweet spot. Report

Drug Delivery News

> Nanotech penetrates prostate cancer cells armed with chemo drugs. Story

> Endo grabs BDSI's drug film chronic pain treatment through global license. Article

> Novel nanoparticles penetrate fruit flies' brains; people's may be next. More

> Civitas' inhaled L-dopa Parkinson's treatment passes Phase I. News

Biomarkers News

> Early blood test could predict baby's sex. News

> Researchers find new lung cancer biomarkers. More

> As genome sequences get cheaper, is more always better? Article

> Immune biomarker could link to autism. Story

Medical Device News

> Ishrak: Medtronic has eyes on overseas acquisitions. Item

> Ventana, Pfizer, CST collaborate on NSCLC companion diagnostic. Article

> Medical imaging company NeuroLogica grabs $12M in funding. Story

> Active Implants rakes in $10M in financing round. News

> Olympus brings suit against current, former execs over accounting scandal. More

And Finally... Scientists have identified compounds in coffee that may play a key role in preventing diabetes. Studies indicate that coffee lovers have a significantly lower risk of developing diabetes. Release

Suggested Articles

Werewolf is launching with $56 million and an approach that can cut through the toxic effects that have limited certain cancer-killing agents.

As Relay looks to enter the clinic in 2020, the company is adding a trio of biopharma vets to its leadership team.

A phase 3 trial of Myovant Sciences’ relugolix in prostate cancer has met its primary endpoint, teeing the company up to file for FDA approval.